Mitsubishi UFJ Morgan Stanley Securities’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-1,300
Closed -$22K 273
2013
Q3
$22K Sell
1,300
-1,700
-57% -$28.6K 0.04% 169
2013
Q2
$46K Buy
+3,000
New +$49.9K 0.15% 80

Other funds holding NVO

Mitsubishi UFJ Morgan Stanley Securities's NVO Position: Q4 2013 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of Novo Nordisk (NVO) in Q4 2013, closing a stake of 1,300 shares — an estimated $22K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in NVO in Q2 2013 and held it in 2 quarters. The position peaked at $46K in Q2 2013. 431 funds tracked by Wall St. Rank hold NVO as of Q4 2013.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining Novo Nordisk position as of Q4 2013 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 1,300 Novo Nordisk shares in Q4 2013, an estimated $22K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Novo Nordisk in Q2 2013 and held it in 2 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's Novo Nordisk position peaked at $46K in Q2 2013.
  • 431 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2013.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q4 2013, filed 13 Feb 2014.